Cargando…

Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY

Understanding of the nucleation process’s fundamental principles in saturated solutions is an urgent task. To do this task, it is necessary to control the formation of polymorphic forms of biologically active compounds. In certain cases, a compound can exist in a single polymorphic form, but have se...

Descripción completa

Detalles Bibliográficos
Autores principales: Eventova, Varvara A., Belov, Konstantin V., Efimov, Sergey V., Khodov, Ilya A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865235/
https://www.ncbi.nlm.nih.gov/pubmed/36678855
http://dx.doi.org/10.3390/pharmaceutics15010226
_version_ 1784875786360061952
author Eventova, Varvara A.
Belov, Konstantin V.
Efimov, Sergey V.
Khodov, Ilya A.
author_facet Eventova, Varvara A.
Belov, Konstantin V.
Efimov, Sergey V.
Khodov, Ilya A.
author_sort Eventova, Varvara A.
collection PubMed
description Understanding of the nucleation process’s fundamental principles in saturated solutions is an urgent task. To do this task, it is necessary to control the formation of polymorphic forms of biologically active compounds. In certain cases, a compound can exist in a single polymorphic form, but have several solvates which can appear in different crystal forms, depending on the medium and conditions of formation, and show different pharmaceutical activity. In the present paper, we report on the analysis of Arbidol conformational preferences in two solvents of different polarities—deuterated chloroform and dimethyl sulfoxide—at 25 °C, using the 2D NOESY method. The Arbidol molecule has various solvate forms depending on the molecular conformation. The method based on the nuclear Overhauser effect spectroscopy was shown to be efficient in the analysis of complex heterocyclic compounds possessing conformation-dependent pseudo-polymorphism. It is one of the types of polymorphism observed in compounds forming crystal solvates. Combined use of NMR methods and X-ray data allowed determining of conformer populations of Arbidol in CDCl(3) and DMSO-d(6) which were found to be 8/92% and 37/63%, respectively. The preferred conformation in solution is the same that appears in stable crystal solvates of Arbidol.
format Online
Article
Text
id pubmed-9865235
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98652352023-01-22 Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY Eventova, Varvara A. Belov, Konstantin V. Efimov, Sergey V. Khodov, Ilya A. Pharmaceutics Communication Understanding of the nucleation process’s fundamental principles in saturated solutions is an urgent task. To do this task, it is necessary to control the formation of polymorphic forms of biologically active compounds. In certain cases, a compound can exist in a single polymorphic form, but have several solvates which can appear in different crystal forms, depending on the medium and conditions of formation, and show different pharmaceutical activity. In the present paper, we report on the analysis of Arbidol conformational preferences in two solvents of different polarities—deuterated chloroform and dimethyl sulfoxide—at 25 °C, using the 2D NOESY method. The Arbidol molecule has various solvate forms depending on the molecular conformation. The method based on the nuclear Overhauser effect spectroscopy was shown to be efficient in the analysis of complex heterocyclic compounds possessing conformation-dependent pseudo-polymorphism. It is one of the types of polymorphism observed in compounds forming crystal solvates. Combined use of NMR methods and X-ray data allowed determining of conformer populations of Arbidol in CDCl(3) and DMSO-d(6) which were found to be 8/92% and 37/63%, respectively. The preferred conformation in solution is the same that appears in stable crystal solvates of Arbidol. MDPI 2023-01-09 /pmc/articles/PMC9865235/ /pubmed/36678855 http://dx.doi.org/10.3390/pharmaceutics15010226 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Eventova, Varvara A.
Belov, Konstantin V.
Efimov, Sergey V.
Khodov, Ilya A.
Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
title Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
title_full Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
title_fullStr Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
title_full_unstemmed Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
title_short Conformational Screening of Arbidol Solvates: Investigation via 2D NOESY
title_sort conformational screening of arbidol solvates: investigation via 2d noesy
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865235/
https://www.ncbi.nlm.nih.gov/pubmed/36678855
http://dx.doi.org/10.3390/pharmaceutics15010226
work_keys_str_mv AT eventovavarvaraa conformationalscreeningofarbidolsolvatesinvestigationvia2dnoesy
AT belovkonstantinv conformationalscreeningofarbidolsolvatesinvestigationvia2dnoesy
AT efimovsergeyv conformationalscreeningofarbidolsolvatesinvestigationvia2dnoesy
AT khodovilyaa conformationalscreeningofarbidolsolvatesinvestigationvia2dnoesy